CXCL1 and essential thrombocythemia: Monocytes were the predominant producer of GRO-α in all patient samples, with the proportion of GRO-α+CD56+CD14+ monocytes being significantly increased in ET patient samples compared to normal controls (p = 0.008, Fig. 2C).